Estimaciones de analistas de Wall Street para Intuitive Surgical, Inc. (ISRG): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-10-20 | $2.61 | ||
| 2026-07-16 | $2.80 | $2.48 | +12.9% |
| 2026-04-21 | $2.80 | $2.51 | +11.6% |
| 2026-01-22 | $2.53 | $2.27 | +11.5% |
| 2025-10-21 | $2.40 | $1.99 | +20.6% |
| 2025-07-22 | $2.19 | $1.93 | +13.5% |
| 2025-04-22 | $1.81 | $1.74 | +4.0% |
| 2025-01-23 | $2.21 | $1.76 | +25.6% |
Ratios de valoración
| Ratio P/E | 44.13 |
| Precio / Valor contable | 7.62 |
| EV / EBITDA | 28.95 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $2.70B | $3.13B | $3.72B | $4.48B | $4.36B | $5.71B | $6.22B | $7.12B | $8.35B | $10.06B |
| Coste de Ventas | $814.3M | $934.8M | $1.12B | $1.37B | $1.50B | $1.75B | $2.03B | $2.39B | $2.72B | $3.42B |
| Beneficio Bruto | $1.89B | $2.19B | $2.60B | $3.11B | $2.86B | $3.96B | $4.20B | $4.73B | $5.63B | $6.64B |
| I+D | $239.6M | $328.6M | $418.1M | $557.3M | $595.1M | $671.0M | $879.0M | $998.8M | $1.15B | $1.31B |
| Generales y Administrativos | $705.3M | $810.9M | $986.6M | $1.18B | $1.22B | $1.47B | $1.74B | $1.96B | $2.14B | $2.38B |
| Gastos Operativos | $944.9M | $1.14B | $1.40B | $1.74B | $1.81B | $2.14B | $2.62B | $2.96B | $3.29B | $3.70B |
| Beneficio Operativo | $945.2M | $1.05B | $1.20B | $1.37B | $1.05B | $1.82B | $1.58B | $1.77B | $2.35B | $2.95B |
| EBITDA | $1.05B | $1.16B | $1.32B | $1.58B | $1.33B | $2.21B | $1.97B | $2.36B | $3.14B | $3.99B |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | $980.8M | $1.10B | $1.28B | $1.50B | $1.21B | $1.89B | $1.61B | $1.96B | $2.67B | $3.31B |
| Impuestos | $244.9M | $436.5M | $154.5M | $120.4M | $140.2M | $162.2M | $262.4M | $141.6M | $336.3M | $434.8M |
| Beneficio Neto | $735.9M | $660.0M | $1.13B | $1.38B | $1.06B | $1.70B | $1.32B | $1.80B | $2.32B | $2.86B |
| BPA | $2.13 | $1.97 | $3.31 | $3.98 | $3.02 | $4.79 | $3.72 | $5.12 | $6.54 | $8.00 |
| BPA Diluido | $2.08 | $1.89 | $3.16 | $3.85 | $2.94 | $4.66 | $3.65 | $5.03 | $6.42 | $7.87 |
| Acciones en Circulación (Diluidas) | $353.7M | $348.9M | $356.4M | $358.5M | $360.9M | $365.8M | $362.0M | $357.4M | $362.0M | $362.7M |
Precio
| Precio | $382.29 |
| Capitalización | $135.1B |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: BAX · BDX · BNGO · COO · EMBC · HOLX · ICUI
Explorar sector: Healthcare · Medical - Instruments & Supplies
Más secciones de ISRG: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones